NCT06419556 Analgesic Efficacy of an Intermediate CPB in Neck Surgeries.
| NCT ID | NCT06419556 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Cairo University |
| Condition | Anesthesia |
| Study Type | INTERVENTIONAL |
| Enrollment | 54 participants |
| Start Date | 2023-03-05 |
| Primary Completion | 2024-06-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 54 participants in total. It began in 2023-03-05 with a primary completion date of 2024-06-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to investigate the analgesic efficacy of Intermediate Cervical Plexus Block combined with GA using two bupivacaine concentrations in patients undergoing neck surgeries (total thyroidectomy or total laryngectomy)
Eligibility Criteria
Inclusion Criteria: * Any patient aged ≥ 40 years * ASA physical status I-III scheduled for total thyroidectomy or total laryngectomy under GA. Exclusion Criteria: * Patients with heart failure * history of arrhythmias * treatment with antiarrhythmic drugs * impaired pulmonary * Liver or kidney functions * Neck infection or rash
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06419556 clinical trial?
This trial is open to participants of all sexes, aged 40 Years or older, up to 70 Years, studying Anesthesia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06419556 currently recruiting?
Yes, NCT06419556 is actively recruiting participants. Contact the research team at nagymalak@kasralainy.edu.eg for enrollment information.
Where is the NCT06419556 trial being conducted?
This trial is being conducted at Cairo, Egypt.
Who is sponsoring the NCT06419556 clinical trial?
NCT06419556 is sponsored by Cairo University. The trial plans to enroll 54 participants.